Literature DB >> 26722545

Hsa-miR-449a genetic variant is associated with risk of gastric cancer in a Chinese population.

Jian Shi1, Yangchen Liu2, Jun Liu3, Juan Zhou3.   

Abstract

Gastric cancer (GC) is one of the most common malignancies and one of the major causes of cancer-related deaths worldwide. In the present study, we investigated the association between miR-449a rs112310158 SNP and GC risk. Our findings revealed that a variant GG genotype increased the risk of occurrence of GC compared to a wild type AA genotype (OR = 2.542, 95% CI: 1.304-4.954, P = 0.005). Specifically, the G allele reduced the risk of occurrence of cervical cancer in women compared to the A allele (OR = 1.279, 95% CI: 1.012-1.617, P = 0.043). In conclusion, our findings suggest that miR-449a rs112310158 is a genetic risk factor for GC.

Entities:  

Keywords:  Gastric cancer; miR-449a; polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26722545      PMCID: PMC4680490     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  29 in total

1.  Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer.

Authors:  Hyo Sung Jeon; Soo Young Lee; Eun Jin Lee; Seong Cheol Yun; Eun Jung Cha; Eugene Choi; Moon Jun Na; Jae Yong Park; Jaeku Kang; Ji Woong Son
Journal:  Lung Cancer       Date:  2011-11-10       Impact factor: 5.705

Review 2.  Structural basis of protein kinase C isoform function.

Authors:  Susan F Steinberg
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

Review 3.  microRNAs in cardiovascular diseases: current knowledge and the road ahead.

Authors:  Gianluigi Condorelli; Michael V G Latronico; Elena Cavarretta
Journal:  J Am Coll Cardiol       Date:  2014-02-26       Impact factor: 24.094

4.  MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions.

Authors:  Girish C Shukla; Jagjit Singh; Sailen Barik
Journal:  Mol Cell Pharmacol       Date:  2011

5.  E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis.

Authors:  M Lizé; S Pilarski; M Dobbelstein
Journal:  Cell Death Differ       Date:  2009-12-04       Impact factor: 15.828

6.  miR-449a targets HDAC-1 and induces growth arrest in prostate cancer.

Authors:  E J Noonan; R F Place; D Pookot; S Basak; J M Whitson; H Hirata; C Giardina; R Dahiya
Journal:  Oncogene       Date:  2009-03-02       Impact factor: 9.867

7.  miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells.

Authors:  Jianghong Hu; Yue Fang; Yuan Cao; Rong Qin; Qiaoyun Chen
Journal:  Dig Dis Sci       Date:  2013-11-19       Impact factor: 3.199

8.  miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells.

Authors:  Emily J Noonan; Robert F Place; Shashwati Basak; Deepa Pookot; Long-Cheng Li
Journal:  Oncotarget       Date:  2010-09

Review 9.  Nature meets nurture: molecular genetics of gastric cancer.

Authors:  Anya N Milne; F Carneiro; C O'Morain; G J A Offerhaus
Journal:  Hum Genet       Date:  2009-08-06       Impact factor: 4.132

10.  ERCC1 single nucleotide polymorphism C8092A, but not its expression is associated with survival of esophageal squamous cell carcinoma patients from Fujian province, China.

Authors:  Wan-Hua Chen; Pei-Ling Xin; Qun-Xiong Pan; Ya-Yun Chen; Cong-Ren Wang; Zhi-Shan Zhang; Yi-Feng Chen; Chao-Yang Zhang; Wen-Jie Cai
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

View more
  6 in total

1.  miR-449a inhibits proliferation and invasion by regulating ADAM10 in hepatocellular carcinoma.

Authors:  Songyang Liu; Kai Liu; Wei Zhang; Yingchao Wang; Zhe Jin; Baoxing Jia; Yahui Liu
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

2.  Association of miR-196a2 rs11614913 and miR-499 rs3746444 polymorphisms with cancer risk: a meta-analysis.

Authors:  Wanjun Yan; Xiaoyan Gao; Shuqun Zhang
Journal:  Oncotarget       Date:  2017-11-20

3.  Investigating the inhibitory effect of miR-34a, miR-449a, miR-1827, and miR-106b on target genes including NOTCH1, c-Myc, and CCND1 in human T cell acute lymphoblastic leukemia clinical samples and cell line.

Authors:  Tohid Naderi; Samira Mohammadi-Yeganeh; Neda Mohammadi-Hezaveh; Razie Hadavi; Ahmad Gharehbaghian; Nader Vazifeh-Shiran; Vahid Fallah Azad; Mahdi Paryan
Journal:  Iran J Basic Med Sci       Date:  2020-03       Impact factor: 2.699

4.  miR-449a Is Related to Short-Term Recurrence of Hepatocellular Carcinoma and Inhibits Migration and Invasion by Targeting Notch1.

Authors:  Bing Han; Jiawei Huang; Zhenjie Yang; Jiaqi Zhang; Xiaomin Wang; Ning Xu; Haining Meng; Junyu Wu; Qiao Huang; Xi Yang; Ruowu Shen; Chuandong Sun
Journal:  Onco Targets Ther       Date:  2019-12-13       Impact factor: 4.147

5.  Clinical significance of microRNA-449a in hepatocellular carcinoma with microarray data mining together with initial bioinformatics analysis.

Authors:  Xia Yang; Han-Lin Wang; Hai-Wei Liang; Liang Liang; Dong-Yue Wen; Rui Zhang; Gang Chen; Dan-Ming Wei
Journal:  Exp Ther Med       Date:  2018-02-05       Impact factor: 2.447

6.  Association between SNPs in microRNA machinery genes and gastric cancer susceptibility, invasion, and metastasis in Chinese Han population.

Authors:  Xingbo Song; Huiyu Zhong; Qian Wu; Minjin Wang; Juan Zhou; Yi Zhou; Xiaojun Lu; Binwu Ying
Journal:  Oncotarget       Date:  2017-09-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.